Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
206.14
USD
+3.79 (+1.87%)
Official Closing Price
Updated: 7:58 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Healthcare Sector Earnings: Making A Comeback In Q1 2017?
April 12, 2017
In 2016, healthcare was the only sector in the S&P 500 (SPX) that ended the year in the red, declining 2.7% versus a positive 12% ...
Tags
Markets
PFE
Analyst Color
From
Benzinga
9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021
April 11, 2017
It is always interesting to see what analysts believe the big new drugs of the year are going to be worth 5 years down the road and Clarivate Analytics has listed the 9 blockbusters their analysts...
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Eli Lilly Targets Hiked By Analysts Bullish On New Drugs
April 11, 2017
JPMorgan raised its price target on Eli Lilly to $100 from $85, as the firm believes that the company is "well-positioned for sustained growth" given the firm's positive outlook on the company's newer...
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
PRESS DIGEST - Wall Street Journal - April 11
April 10, 2017
April 11 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Tags
companyNews
From
Reuters: Company News
Biotechs Split: Axovant Rides CEO Swap, But Celgene Partner Dives
April 10, 2017
Axovant and OncoMed split the biotech sector Monday as Axovant stock popped on its CEO swap and OncoMed stock toppled on a failed drug trial.
Tags
Technology
From
Investor's Business Daily
XLV, LLY, ABT, AET: ETF Inflow Alert
April 10, 2017
Symbols mentioned in this story: XLV, LLY, ABT, AET Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
5 Pharmaceutical Stocks With the Most Reliable Dividends
April 09, 2017
Tags
ABBV
JNJ
NVO
From
Motley Fool
FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements
April 07, 2017
The U.S. Food and Drug Administration has issued a series of warnings about a handful of over-the-counter male sexual enhancement ...
Tags
Benzinga
Cialis
LLY
From
Benzinga
Boehringer eyes marked sales gain, boosted by animal health
April 04, 2017
INGELHEIM, Germany, April 5 (Reuters) - Boehringer Ingelheim, Germany's second-largest drugmaker, said on Wednesday it was targeting a marked gain in 2017 revenues, boosted by new animal health...
Tags
companyNews
From
Reuters: Company News
Eli Lilly (LLY) Breaks Through Resistance at $84.82
April 04, 2017
Shares of Eli Lilly (NYSE:LLY) have bullishly opened above the pivot of $84.44 today and have reached the first resistance level of $84.82. Investors may be interested in a...
From
Comtex SmarTrend® News Briefs
4 Drug Stocks With Big News Coming in April
April 02, 2017
Tags
BMRN
INCY
LLY
From
Motley Fool
Will Trump's FDA Chill Innovation Or Kill 'Astronomical' Prices?
March 31, 2017
It seems clear President Trump wants a leaner and meaner Food and Drug Administration, but how lean and how mean?
Tags
Technology
From
Investor's Business Daily
BRIEF-Eli Lilly says Lilly Endowment Inc reports open market sale of 210,000 of stock
March 31, 2017
* Lilly Endowment Inc reports open market sale of 210,000 of co's common stock on march 30 at $84.674 per share - SEC filing Source text (http://bit.ly/2nrnkag) Further company coverage:
Tags
companyNews
From
Reuters: Company News
Here's Why Halozyme Therapeutics, Inc Is Falling
March 30, 2017
Tags
CELG
HALO
LLY
From
Motley Fool
Interesting LLY Put And Call Options For May 12th
March 30, 2017
Investors in Lilly (Eli) & Co (LLY) saw new options begin trading today, for the May 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for...
Tags
Stocks
From
Market News Video
'Legislative risk' on drug prices is greater now, Citi says
March 29, 2017
Drugmakers may soon face renewed pressure on high prices, now that Republicans have pulled their American Health Care Act, Citi says.
Tags
Places/North America/United States
GlaxoSmithKline PLC
Eli Lilly and Co
From
CNBC.com News
Noteworthy ETF Outflows: IYH, MDT, LLY, ABT
March 29, 2017
Symbols mentioned in this story: IYH, MDT, LLY, ABT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
BRIEF-Intelgenx Technologies says Eli Lilly granted Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent
March 28, 2017
* Intelgenx Technologies- Eli Lilly granted Intelgenx' Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent
Tags
companyNews
From
Reuters: Company News
LPC: Top US firms raise loans on tax reform hopes
March 24, 2017
NEW YORK, March 24 (Reuters) - Top US companies are raising 364-day syndicated loans to keep financial flexibility while they wait for details of a proposed tax windfall as the Trump administration...
Tags
companyNews
From
Reuters: Company News
UPDATE 1-Drugmaker Lilly to invest $850 mln in U.S. operations in 2017
March 24, 2017
March 24 (Reuters) - Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year, and the drugmaker signaled it would be willing to spend more if the Trump...
Tags
companyNews
From
Reuters: Company News
BRIEF-Eli Lilly announces $850 mln investment in U.S. capital projects in 2017
March 24, 2017
* Lilly announces $850 million investment in U.S. capital projects in 2017
Tags
companyNews
From
Reuters: Company News
Drugmaker Lilly to invest $850 mln in U.S. operations in 2017
March 24, 2017
March 24 (Reuters) - Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year.
Tags
companyNews
From
Reuters: Company News
Cramer's best and worst case scenarios for the health-care vote
March 23, 2017
Jim Cramer sees opportunity whichever way the Obamacare vote swings.
Tags
Investing/Indexes/S&P 500
Investing/Stock Market
Investing
From
CNBC.com News
BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly
March 23, 2017
* Ignyta announces exploration of strategic options for Taladegib, enabled by amendment of Taladegib license agreement with Lilly
Tags
companyNews
From
Reuters: Company News
Novartis Leadership In Psoriasis Therapies Could Be Consolidated With New Drug "Cosentyx"
March 21, 2017
The pharma giant Novartis is looking to consolidate its hold on the lead role for new therapies for psoriasis with some remarkable data suggesting the drug could act as a disease modifier for a...
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Gotham Index "Plus": A Better Way To Invest?
March 20, 2017
I am buying an index fund – with an important twist. This twist is brought to us by the Dynamic Duo of Joel Greenblatt and Robert Goldstein
Tags
Mutual Funds
From
Blogs - TalkMarkets
Competition Increases Between Novartis, Lilly & Pfizer For Approval Of New Breast Cancer Drug
March 20, 2017
Just one week after Novartis scored a key approval for its CDK 4/6 cancer drug, Eli Lilly & Co. has announced that its long-awaited Phase III readout for its rival drug "abemaciclib" looks good albeit...
Tags
Healthcare
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Why Amgen's Success Was a Big Disappointment
March 20, 2017
Tags
NVS
LLY
AMGN
From
Motley Fool
BRIEF-Eli Lilly and Co says CEO John Lechleiter's 2016 total compensation was $18.4 mln
March 20, 2017
* CEO John C. Lechleiter's 2016 total compensation was $18.4 million versus $16.6 million in 2015
Tags
companyNews
From
Reuters: Company News
UPDATE 3-Lilly's breast cancer drug combination succeeds key study
March 20, 2017
* To submit marketing application for mono, combo therapy in 2017
Tags
companyNews
From
Reuters: Company News
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.